O	0	10	Evaluation
O	11	13	of
B-Disease	14	20	ocular
I-Disease	21	28	surface
I-Disease	29	36	disease
O	37	39	in
O	40	48	patients
O	49	53	with
B-Disease	54	62	glaucoma
O	62	63	.

O	65	67	To
O	68	76	evaluate
O	77	80	the
O	81	91	subjective
O	92	95	and
O	96	105	objective
O	106	114	measures
O	115	117	of
B-Disease	118	124	ocular
I-Disease	125	132	surface
I-Disease	133	140	disease
O	141	143	in
O	144	152	patients
O	153	157	with
B-Disease	158	166	glaucoma
O	166	167	.

O	168	173	Cross
O	173	174	-
O	174	183	sectional
O	184	189	study
O	189	190	.

O	191	196	Sixty
O	196	197	-
O	197	201	four
B-Disease	202	210	glaucoma
O	211	219	subjects
O	220	224	with
B-Symptom	225	234	bilateral
I-Symptom	235	241	visual
I-Symptom	242	247	field
I-Symptom	248	249	(
I-Symptom	249	251	VF
I-Symptom	251	252	)
I-Symptom	253	257	loss
O	258	261	and
O	262	264	59
B-Disease	265	273	glaucoma
I-Disease	274	282	suspects
O	283	287	with
B-Symptom	288	294	normal
I-Symptom	295	298	VFs
O	298	299	.

O	300	311	Consecutive
O	312	320	patients
O	321	325	were
O	326	335	recruited
O	336	349	prospectively
O	350	354	from
O	355	358	the
O	359	365	Wilmer
O	366	369	Eye
O	370	379	Institute
B-Disease	380	388	Glaucoma
O	389	395	Clinic
O	395	396	.

B-Characteristic	397	401	Tear
I-Characteristic	402	406	film
I-Characteristic	407	414	breakup
I-Characteristic	415	419	time
O	420	421	(
B-Characteristic	421	425	TBUT
O	425	426	)
O	426	427	,
B-Characteristic	428	435	corneal
I-Characteristic	436	444	staining
I-Characteristic	445	450	score
O	451	452	(
O	452	453	0
O	453	454	-
O	454	456	15
O	456	457	)
O	457	458	,
O	459	462	and
B-Characteristic	463	471	Schirmer
I-Characteristic	471	472	'
I-Characteristic	472	473	s
I-Characteristic	474	478	test
I-Characteristic	479	486	results
O	487	491	were
O	492	500	included
O	501	503	as
O	504	513	objective
O	514	521	metrics
O	521	522	,
O	523	530	whereas
O	531	534	the
B-Characteristic	535	541	Ocular
I-Characteristic	542	549	Surface
I-Characteristic	550	557	Disease
I-Characteristic	558	563	Index
O	564	565	(
B-Characteristic	565	569	OSDI
O	569	570	)
O	571	584	questionnaire
O	585	588	was
O	589	601	administered
O	602	604	to
O	605	611	assess
O	612	620	symptoms
O	620	621	.

B-Characteristic	622	627	Total
I-Characteristic	628	632	OSDI
I-Characteristic	633	638	score
O	638	639	,
B-Characteristic	640	646	vision
I-Characteristic	646	647	-
I-Characteristic	647	654	related
I-Characteristic	655	663	subscore
O	664	665	(
O	665	672	derived
O	673	677	from
O	678	687	questions
O	688	693	about
O	694	700	vision
O	701	704	and
O	705	709	task
O	710	721	performance
O	721	722	)
O	722	723	,
O	724	727	and
B-Characteristic	728	738	discomfort
I-Characteristic	738	739	-
I-Characteristic	739	746	related
I-Characteristic	747	755	subscore
O	756	757	(
O	757	764	derived
O	765	769	from
O	770	779	questions
O	780	785	about
O	786	792	ocular
O	793	800	surface
O	801	811	discomfort
O	811	812	)
O	813	817	were
O	818	828	calculated
O	829	832	for
O	833	837	each
O	838	845	subject
O	845	846	.

O	847	854	Seventy
O	854	855	-
O	855	859	five
O	860	867	percent
O	868	869	(
O	869	871	48
O	871	872	/
O	872	874	64
O	874	875	)
O	876	878	of
B-Disease	879	887	glaucoma
O	888	896	subjects
O	897	900	and
O	901	903	41
O	903	904	%
O	905	906	(
O	906	908	24
O	908	909	/
O	909	911	59
O	911	912	)
O	913	915	of
B-Disease	916	924	glaucoma
I-Disease	925	933	suspects
O	934	938	were
O	939	948	receiving
O	949	956	topical
O	957	968	medications
O	968	969	.

O	970	973	The
B-Characteristic	974	981	corneal
I-Characteristic	982	990	staining
I-Characteristic	991	996	grade
O	997	1000	was
O	1001	1008	greater
O	1009	1011	in
B-Disease	1012	1020	glaucoma
O	1021	1029	subjects
O	1030	1034	than
O	1035	1037	in
B-Disease	1038	1046	glaucoma
I-Disease	1047	1055	suspects
O	1056	1057	(
O	1057	1058	6
O	1058	1059	.
O	1059	1060	4
O	1061	1063	vs
O	1063	1064	.
O	1065	1066	4
O	1066	1067	.
O	1067	1068	1
O	1068	1069	;
O	1070	1071	P
O	1072	1073	<
O	1074	1075	0
O	1075	1076	.
O	1076	1079	001
O	1079	1080	)
O	1080	1081	,
O	1082	1085	but
O	1086	1092	groups
O	1093	1096	did
O	1097	1100	not
O	1101	1107	differ
O	1108	1112	with
O	1113	1119	regard
O	1120	1122	to
B-Characteristic	1123	1127	TBUT
O	1128	1130	or
B-Characteristic	1131	1139	Schirmer
I-Characteristic	1139	1140	'
I-Characteristic	1140	1141	s
I-Characteristic	1142	1149	results
O	1150	1151	(
O	1151	1152	P
O	1153	1154	>
O	1155	1156	0
O	1156	1157	.
O	1157	1159	20
O	1160	1163	for
O	1164	1168	both
O	1168	1169	)
O	1169	1170	.

O	1171	1183	Multivariate
O	1184	1194	regression
O	1195	1201	models
O	1202	1208	showed
O	1209	1213	that
B-Characteristic	1214	1221	topical
I-Characteristic	1222	1230	glaucoma
I-Characteristic	1231	1238	therapy
I-Characteristic	1239	1245	burden
O	1246	1249	was
O	1250	1260	associated
O	1261	1265	with
O	1266	1267	a
O	1268	1281	significantly
O	1282	1288	higher
B-Characteristic	1289	1294	total
I-Characteristic	1295	1302	corneal
I-Characteristic	1303	1311	staining
I-Characteristic	1312	1317	grade
O	1318	1319	(
O	1319	1320	β
O	1320	1321	,
O	1322	1323	+
O	1323	1324	0
O	1324	1325	.
O	1325	1326	9
O	1327	1330	for
O	1331	1335	each
O	1336	1346	additional
O	1347	1355	glaucoma
O	1356	1360	drop
O	1360	1361	;
O	1362	1364	95
O	1364	1365	%
O	1366	1376	confidence
O	1377	1385	interval
O	1386	1387	[
O	1387	1389	CI
O	1389	1390	]
O	1390	1391	,
O	1392	1393	0
O	1393	1394	.
O	1394	1395	5
O	1395	1396	-
O	1396	1397	1
O	1397	1398	.
O	1398	1399	3
O	1399	1400	;
O	1401	1402	P
O	1403	1404	<
O	1405	1406	0
O	1406	1407	.
O	1407	1410	001
O	1410	1411	)
O	1411	1412	,
O	1413	1416	but
O	1417	1420	not
O	1421	1425	with
B-Characteristic	1426	1430	TBUT
O	1431	1433	or
B-Characteristic	1434	1442	Schirmer
I-Characteristic	1442	1443	'
I-Characteristic	1443	1444	s
I-Characteristic	1445	1452	results
O	1453	1454	(
O	1454	1455	P
O	1456	1457	>
O	1458	1459	0
O	1459	1460	.
O	1460	1462	20
O	1463	1466	for
O	1467	1471	both
O	1471	1472	)
O	1472	1473	.

B-Disease	1474	1482	Glaucoma
O	1483	1491	subjects
O	1492	1495	had
O	1496	1509	significantly
O	1510	1516	higher
B-Characteristic	1517	1522	total
I-Characteristic	1523	1527	OSDI
I-Characteristic	1528	1534	scores
O	1535	1539	than
B-Disease	1540	1548	glaucoma
I-Disease	1549	1557	suspects
O	1558	1559	(
O	1559	1561	16
O	1561	1562	.
O	1562	1563	7
O	1564	1566	vs
O	1566	1567	.
O	1568	1569	7
O	1569	1570	.
O	1570	1571	9
O	1571	1572	;
O	1573	1574	P
O	1575	1576	<
O	1577	1578	0
O	1578	1579	.
O	1579	1582	001
O	1582	1583	)
O	1583	1584	.

O	1585	1589	This
O	1590	1597	largely
O	1598	1601	was
O	1602	1605	the
O	1606	1612	result
O	1613	1615	of
O	1616	1622	higher
B-Characteristic	1623	1629	vision
I-Characteristic	1629	1630	-
I-Characteristic	1630	1637	related
I-Characteristic	1638	1647	subscores
O	1648	1650	in
O	1651	1654	the
B-Disease	1655	1663	glaucoma
O	1664	1669	group
O	1670	1671	(
O	1671	1673	11
O	1673	1674	.
O	1674	1675	1
O	1676	1678	vs
O	1678	1679	.
O	1680	1681	3
O	1681	1682	.
O	1682	1683	3
O	1683	1684	;
O	1685	1686	P
O	1687	1688	<
O	1689	1690	0
O	1690	1691	.
O	1691	1694	001
O	1694	1695	)
O	1695	1696	.

B-Characteristic	1697	1703	Ocular
I-Characteristic	1704	1714	discomfort
I-Characteristic	1714	1715	-
I-Characteristic	1715	1722	related
I-Characteristic	1723	1732	subscores
O	1732	1733	,
O	1734	1741	however
O	1741	1742	,
O	1743	1747	were
O	1748	1755	similar
O	1756	1758	in
O	1759	1763	both
O	1764	1770	groups
O	1771	1772	(
O	1772	1773	5
O	1773	1774	.
O	1774	1775	7
O	1776	1778	vs
O	1778	1779	.
O	1780	1781	4
O	1781	1782	.
O	1782	1783	6
O	1783	1784	;
O	1785	1786	P
O	1787	1788	=
O	1789	1790	0
O	1790	1791	.
O	1791	1793	30
O	1793	1794	)
O	1794	1795	.

O	1796	1798	In
O	1799	1811	multivariate
O	1812	1820	analyses
O	1820	1821	,
O	1822	1826	each
O	1827	1828	5
O	1828	1829	-
O	1829	1836	decibel
O	1837	1846	decrement
O	1847	1849	in
B-Characteristic	1850	1856	better
I-Characteristic	1856	1857	-
I-Characteristic	1857	1860	eye
I-Characteristic	1861	1863	VF
I-Characteristic	1864	1868	mean
I-Characteristic	1869	1878	deviation
O	1879	1882	was
O	1883	1893	associated
O	1894	1898	with
O	1899	1900	a
O	1901	1902	4
O	1902	1903	.
O	1903	1904	7
O	1904	1905	-
O	1905	1910	point
O	1911	1919	increase
O	1920	1922	in
B-Characteristic	1923	1928	total
I-Characteristic	1929	1933	OSDI
I-Characteristic	1934	1939	score
O	1940	1941	(
O	1941	1943	95
O	1943	1944	%
O	1945	1947	CI
O	1947	1948	,
O	1949	1950	1
O	1950	1951	.
O	1951	1952	9
O	1952	1953	-
O	1953	1954	7
O	1954	1955	.
O	1955	1956	5
O	1956	1957	;
O	1958	1959	P
O	1960	1961	=
O	1962	1963	0
O	1963	1964	.
O	1964	1967	001
O	1967	1968	)
O	1969	1972	and
O	1973	1974	a
O	1975	1976	3
O	1976	1977	.
O	1977	1978	7
O	1978	1979	-
O	1979	1984	point
O	1985	1993	increase
O	1994	1996	in
O	1997	2000	the
B-Characteristic	2001	2007	vision
I-Characteristic	2007	2008	-
I-Characteristic	2008	2015	related
I-Characteristic	2016	2024	subscore
O	2025	2026	(
O	2026	2028	95
O	2028	2029	%
O	2030	2032	CI
O	2032	2033	,
O	2034	2035	1
O	2035	2036	.
O	2036	2037	7
O	2037	2038	-
O	2038	2039	5
O	2039	2040	.
O	2040	2041	6
O	2041	2042	;
O	2043	2044	P
O	2045	2046	<
O	2047	2048	0
O	2048	2049	.
O	2049	2052	001
O	2052	2053	)
O	2054	2057	but
O	2058	2061	did
O	2062	2065	not
O	2066	2073	predict
O	2074	2075	a
O	2076	2082	higher
B-Characteristic	2083	2093	discomfort
I-Characteristic	2093	2094	-
I-Characteristic	2094	2101	related
I-Characteristic	2102	2110	subscore
O	2111	2112	(
O	2112	2113	β
O	2113	2114	,
O	2115	2116	1
O	2116	2117	.
O	2117	2118	1
O	2119	2124	point
O	2124	2125	;
O	2126	2127	P
O	2128	2129	=
O	2130	2131	0
O	2131	2132	.
O	2132	2134	07
O	2134	2135	)
O	2135	2136	.

B-Characteristic	2137	2144	Topical
I-Characteristic	2145	2153	glaucoma
I-Characteristic	2154	2161	therapy
I-Characteristic	2162	2168	burden
O	2169	2172	was
O	2173	2176	not
O	2177	2187	associated
O	2188	2192	with
O	2193	2199	higher
B-Characteristic	2200	2205	total
I-Characteristic	2206	2210	OSDI
I-Characteristic	2211	2216	score
O	2217	2219	or
B-Characteristic	2220	2226	vision
I-Characteristic	2226	2227	-
I-Characteristic	2228	2230	or
I-Characteristic	2231	2241	discomfort
I-Characteristic	2241	2242	-
I-Characteristic	2242	2249	related
I-Characteristic	2250	2258	subscore
O	2259	2260	(
O	2260	2261	P
O	2262	2263	>
O	2264	2265	0
O	2265	2266	.
O	2266	2268	20
O	2269	2272	for
O	2273	2276	all
O	2276	2277	)
O	2277	2278	.

B-Disease	2279	2287	Glaucoma
O	2288	2290	is
O	2291	2301	associated
O	2302	2306	with
O	2307	2318	significant
B-Disease	2319	2325	ocular
I-Disease	2326	2333	surface
I-Disease	2334	2341	disease
O	2341	2342	,
O	2343	2346	and
B-Characteristic	2347	2354	topical
I-Characteristic	2355	2363	glaucoma
I-Characteristic	2364	2371	therapy
I-Characteristic	2372	2378	burden
O	2379	2384	seems
O	2385	2395	predictive
O	2396	2398	of
B-Characteristic	2399	2406	corneal
I-Characteristic	2407	2415	staining
I-Characteristic	2416	2424	severity
O	2424	2425	.

O	2426	2433	However
O	2433	2434	,
B-Characteristic	2435	2439	OSDI
O	2440	2442	is
O	2443	2444	a
O	2445	2449	poor
O	2450	2456	metric
O	2457	2460	for
O	2461	2470	capturing
B-Disease	2471	2477	ocular
I-Disease	2478	2485	surface
I-Disease	2486	2493	disease
O	2494	2496	in
B-Disease	2497	2505	glaucoma
O	2506	2513	because
O	2514	2522	symptoms
O	2523	2527	seem
O	2528	2530	to
O	2531	2533	be
O	2534	2541	related
O	2542	2549	largely
O	2550	2552	to
B-Symptom	2553	2555	VF
I-Symptom	2556	2560	loss
O	2560	2561	.
